United States · FDA National Drug Code directory
VIBATIV
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 66220-315_7664f8a4-33c4-4f30-998e-86333640c44d
- Product NDC
- 66220-315
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- telavancin hydrochloride
- Labeler
- Cumberland Pharmaceuticals Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20210101
- Source listing expiry
- 20261231
Source-listed ingredients
- TELAVANCIN HYDROCHLORIDE — 15 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (66220-315-11) / 50 mL in 1 VIAL, SINGLE-DOSE · 66220-315-11
- 12 VIAL, SINGLE-DOSE in 1 CARTON (66220-315-22) / 50 mL in 1 VIAL, SINGLE-DOSE · 66220-315-22
- 4 VIAL, SINGLE-DOSE in 1 CARTON (66220-315-44) / 50 mL in 1 VIAL, SINGLE-DOSE · 66220-315-44
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →